Junfeng Wang is listed as a director on 3 SEC Form D filings by 1 issuer between Jul 2018 and Oct 2020: Urotronic, Inc. (Plymouth, MN — other health care — 2018–2020; $20M reported sold to 26 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside David Perry (3 shared filings), Doug Kohrs (3 shared filings), Hui Hu (3 shared filings), Lixiao Wang (3 shared filings), Tan Ching (3 shared filings) and 3 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Junfeng. Each name links to their own page.
The issuer belongs to the sponsor group Urotronic (2 issuers, $13.4M reported sold, 2018–2020).
What this means A sponsor group is one team that sets up a new company for each deal. Urotronic has 2 companies on file and $13.4M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Junfeng Wang and found 3 differences, 1 worth asking the sponsor about: Form D filed 112 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.